Indole amide derivatives as EP4 receptor antagonists

Details Indole amide derivatives as EP4 receptor antagonists Indole amide derivatives as EP4 receptor antagonists

2011-06-28

2011-06-28

Young, Shawquia (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S379000, C514S394000, C514S406000, C514S415000, C514S416000, C548S207000, C548S241000, C548S261000, C548S304400, C548S362500, C548S494000

Reexamination Certificate

active

07968578

ABSTRACT:
The invention is directed to indole amide derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutical compositions and methods of use are also included.

REFERENCES:
patent: 4221815 (1980-09-01), Weyer et al.
patent: 2005/0065188 (2005-03-01), Nakao et al.
patent: 2006/0281750 (2006-12-01), Li et al.
patent: 2007/0123561 (2007-05-01), Lee et al.
patent: 0 166 591 (1986-01-01), None
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL http://www.nlm.nih.gov/medlineplus/cancer.html>.
Cancer [online], [retrieved on Jun. 9, 2007]. Retrieved from the internet, URL; http://en.wikipedia.orglwikilCancer.

Affiliated with

Also associated with

Rating

Indole amide derivatives as EP4 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole amide derivatives as EP4 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole amide derivatives as EP4 receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2639417